Why Multiples Can Be Misleading: The Hidden Traps in Relative Valuation

Valuation multiples are seductive. A stock trading at 12x earnings while its peers average 18x looks cheap—a bargain screaming to be bought. Yet this apparent discount often conceals deeper problems: the company may earn those cheap dollars through accounting tricks, competitor strength may be eroding, or the entire peer group may be overvalued. This chapter examines the systematic flaws that make multiples misleading and how to navigate them.

Quick Definition

A valuation multiple is a ratio comparing a company's market value (or share price) to a financial metric—earnings, revenue, book value, or cash flow. Multiples like P/E, P/S, and EV/EBITDA rank companies relative to peers, but they conflate quality, risk, growth, and accounting choices into a single number. A low multiple may signal value or signal trouble. The difference matters enormously.

Key Takeaways

• Earnings quality varies widely: Two companies with identical P/E ratios may have vastly different earnings durability if one uses aggressive accounting or one-time gains.
• Survivorship bias distorts peer groups: Failed competitors are removed from benchmarks, inflating average multiples and making survivors look cheaper than true risk-adjusted cost.
• Cyclical earnings create traps: A low P/E during a boom masks the fact that earnings will mean-revert downward, disappointing buyers.
• Multiples ignore growth and risk: A fast-growing, stable business should trade at a higher multiple than a mature, volatile one—but multiples don't always reflect this.
• Accounting manipulation narrows comparability: One company's EBITDA may include real costs that another excludes, making multiples incomparable across firms.
• One metric hides many stories: Focusing on a single multiple (like P/E) obscures leverage, asset quality, and capital allocation—each material to actual value.

The Earnings Quality Problem

The most common trap is assuming that similar earnings multiples reflect similar business quality. They often do not. Two companies reporting $10 per share in earnings may be fundamentally different.

Company A achieves earnings through core operations: selling products, generating sustainable gross margins, and reinvesting for growth. Earnings are repeatable.

Company B reports the same $10, but $4 comes from selling off corporate real estate and $3 from a one-time gain on a pension settlement. Core operating earnings are $3. The true recurrence rate is much lower.

If both trade at 15x reported earnings, Company A is far more expensive—and worth it. Multiples fail to distinguish because they treat all earnings identically. This is why experienced analysts adjust reported figures: they strip out one-time gains, normalize cyclical downturns, and assess the durability of what remains.

The problem deepens with aggressive accounting choices allowed within GAAP:

• Revenue recognition: A software firm recognizing upfront SaaS revenue inflates current earnings relative to a competitor using appropriate deferral.
• Depreciation and amortization: A capital-light technology company reports high earnings; a manufacturing firm in the same industry reports low earnings, yet both may be equally profitable after adjusting for asset bases and reinvestment needs.
• Provisions and write-downs: A company that takes large annual impairments reports lower earnings than one that defers the same problem, yet the economic reality is identical.

These choices are legal, even disclosed, but multiples treat them the same. The investor who buys the cheap multiple based on headline earnings may be buying illusion.

Survivorship Bias and Peer Selection

When you benchmark a stock against "the industry average," you are not comparing against all companies that competed. You are comparing against survivors—the companies that made it to the current valuation period. The weaker competitors have been acquired, failed, or delisted.

This creates a selection bias: the surviving peer group is, by definition, more successful than the broader competitive ecosystem was. Average multiples are therefore artificially inflated.

Example: In 2008, before the financial crisis truly hit, U.S. automakers traded at what looked like attractive multiples relative to their historical averages. But the peer group did not include the now-defunct companies or the severe restructurings ahead. The "average" was not representative of long-run economics. Buyers who used then-current peer multiples bought deteriorating franchises.

Similarly, in high-growth industries, the survivors are usually the strongest. A biotech company trading at a 40% discount to its surviving peers may truly be cheaper—or it may be the weakest of the group, and the discount reflects material risk that the multiple approach misses.

To correct for this, some analysts use a broader cohort—including historical peers, international competitors, and adjacent industries. But this introduces a new problem: less comparable firms skew the multiple higher or lower based on differences that have nothing to do with relative value.

The Cyclicality Trap

Many businesses have cyclical earnings. During a boom, earnings surge; during a recession, they collapse. A low P/E multiple during a boom often signals not that the stock is cheap, but that earnings are at a peak and about to fall sharply.

Steel mills, automakers, and banks are classics. A regional bank might trade at 0.8x tangible book value near the end of an expansion, with reported ROE of 15%. The multiple looks attractive. But within 18 months, loan losses spike, earnings plummet, and the stock falls 40%. The "cheap" multiple was cheap because market participants—consciously or not—anticipated mean reversion in cyclical earnings.

The inverse trap is also common: during a trough, earnings are depressed, the multiple looks expensive, and the stock is actually cheap because earnings will recover. Buying the depressed multiple at the trough requires knowing where you are in the cycle—information that multiples alone do not provide.

Correcting for this requires normalizing earnings to a mid-cycle level: estimate what the company would earn in an average year, not at a peak or trough. This is harder than comparing to last year's results, which is why many investors fall into the trap.

Growth and Risk Blindness

A fundamental law of valuation is that higher growth and lower risk justify higher multiples. Yet a multiple tells you nothing about either.

Two companies with identical P/E ratios may have very different growth profiles. Company X grows 5% annually; Company Y grows 20%. If anything, Y should trade at a higher multiple, not the same. Yet if both earn $1 per share, have similar margins, and both trade at 15x, multiples hide this critical difference.

Similarly, multiples ignore leverage and financial risk. A company with 2x net debt should trade at a lower multiple than a debt-free peer, all else equal—higher financial risk warrants a lower valuation. But a simple P/E ratio is blind to capital structure. An analyst must adjust independently.

This is why experienced practitioners use EV/EBITDA or EV/FCF instead of P/E: they normalize for capital structure. But even these better multiples require manual assessment of growth and risk. The multiple itself provides no adjustment.

Accounting Manipulation and Non-Comparability

GAAP allows significant discretion in how costs and revenues are categorized. This discretion is lawful and disclosed, but it undermines multiples.

Outsourcing example: Company A outsources distribution, so its supply-chain costs are in COGS. Company B owns distribution, so large depreciation is in operating expenses. Both have the same economic profit, but different EBITDA. Comparing EV/EBITDA multiples directly is misleading; the analyst must restate one to match the other's model.

Stock-based compensation: Some companies value equity grants at grant-date fair value; others use intrinsic value or exclude them from adjusted EBITDA. A peer group with mixed practices becomes incomparable.

Capitalization vs. expensing: A company that capitalizes and amortizes marketing costs reports higher EBITDA than one that expenses them, even if both spend the same dollar amount. The multiples diverge not because of business quality, but due to accounting choice.

Correcting these requires line-item restatement of competitors' financials—tedious work that most casual investors skip. Yet without it, multiples are apples-to-oranges comparisons.

The Single-Metric Myopia

Many investors focus on a single multiple—often P/E—as if it captures everything. It does not.

A company can have a low P/E because:

1. The market undervalues stable, predictable cash flows (a genuine bargain).
2. Earnings are peaked and about to fall (a value trap).
3. Accounting choices inflate earnings (an illusion).
4. The company has hidden liabilities or contingencies (a disclosure failure).
5. The industry is structurally declining (a secular trend).

Multiples cannot distinguish between these. Only deep analysis does. Yet multiples are easy to calculate and easy to publish, so they dominate financial media and screening tools. The result is that the simplest, most misleading metric often drives retail investment.

Professional investors compensate by using multiple metrics simultaneously: P/E, EV/EBITDA, P/B, Price/FCF, and dozens more. The patterns across metrics often reveal the real story. If a stock is cheap on P/E but expensive on EV/FCF and P/B, the low P/E likely masks high leverage or earnings quality issues.

Visualization: The Sources of Multiple Divergence

Real-World Examples

The Finance Crisis and Bank Multiples (2008)

In mid-2008, Lehman Brothers traded at roughly 0.8x tangible book value, a multiple that looked attractive versus a historical average of 1.1x. Similarly, Merrill Lynch and Morgan Stanley traded at discounts to peers. The multiples were genuinely cheap—because the market had begun pricing in the collapse of their business models. Investors who used multiples to buy "cheap" financials during the crisis lost everything.

The peer-group average was misleading because the peer group itself was about to shrink dramatically. Survivorship bias was severe. Analysis of capital adequacy, liquidity, and asset quality would have revealed the danger; multiples alone did not.

Tech Valuations and Revenue Multiples (2021–2022)

During the 2020–2021 bull market, unprofitable tech companies were valued at enormous revenue multiples: 20x, 30x, or more. Profitability was dismissed as temporary—the companies were "investing for growth." Yet multiples tell you nothing about path to profitability or unit economics. When interest rates rose in 2022 and venture funding dried up, these companies' multiples compressed sharply, and many fell 50–80%.

A multiple-based investor in 2021 would have seen revenue multiples and bought. A fundamentals-based investor would have asked: at what margin do these companies eventually operate? When do they hit cash flow breakeven? Are those dates realistic? The multiples hid the risks.

Citigroup's Accounting Complexity (2010s)

Citigroup traded at low tangible book multiples throughout the post-crisis decade, appearing cheaper than peers. Yet the low multiple reflected uncertainty about earnings quality, hidden leverage in complex derivatives books, and questions about actual return on equity. Multiples could not decompose these drivers; only detailed financial statement analysis could. The stock eventually recovered, but not because the multiple was cheap—because the underlying business stabilized.

Common Mistakes

Mistake 1: Treating the Cheapest Multiple as the Best Buy

The stock with the lowest P/E ratio is not the best value. It is the cheapest by one metric. It may be cheap for excellent reasons (a genuine bargain) or terrible reasons (a collapsing business). Multiples are a screening tool, not an investment thesis.

Mistake 2: Using the Industry Average as Ground Truth

The average P/E of an industry is not a "fair" multiple; it is the average of the current composition of survivors, all of whom are uncertain about the future. If 80% of the companies in an industry are overvalued, the average is overvalued, and comparing a stock to that average is comparing apples to inflated apples.

Mistake 3: Ignoring Quality and Growth Differences

Two companies with identical P/E ratios are not equally attractive if one grows twice as fast or has twice the return on equity. Multiples are blind to quality. You must adjust manually or use quality-adjusted multiples (like PEG, price-to-growth).

Mistake 4: Accepting Headline Earnings Without Adjustment

A company's reported earnings per share is not pure income. It may include one-time gains, use aggressive recognition, or exclude stock-based compensation. Compare adjusted or normalized earnings, not headlines.

Mistake 5: Focusing on a Single Multiple

If a stock looks cheap on P/E but expensive on EV/FCF, price-to-book, and enterprise-value-to-sales, the low P/E is almost certainly a trap. Use multiple metrics; look for agreement across them.

FAQ

Q: Are multiples ever useful, or should I always ignore them?

A: Multiples are useful as screening and comparison tools. They are fast and transparent. But they should never be the sole basis for investment. Use them to identify candidates for deeper analysis, then dig into earnings quality, competitive position, growth runway, and capital allocation.

Q: How do I adjust multiples for earnings quality?

A: Start with the company's financial statements. Add back one-time gains; subtract temporary benefits (like a below-market interest rate on a single contract). Estimate normalized or mid-cycle earnings. Then recalculate the multiple using this adjusted figure. It is labor-intensive, but it is how professionals identify true bargains.

Q: Should I only invest in cheap multiples?

A: No. A quality company growing at 20% per year and earning a 20% return on equity is worth a premium multiple, even if the current multiple looks high. Pay up for quality and growth when you can verify both. The cheapest multiple is often cheap for a reason.

Q: What multiple should I use: P/E, EV/EBITDA, or something else?

A: Use multiple metrics. P/E is simple but blind to leverage. EV/EBITDA normalizes for capital structure. Price/FCF is closest to economic reality. Look for agreement across metrics; divergence often signals a problem.

Q: How do I correct for cyclicality?

A: Estimate normalized or mid-cycle earnings by looking at a multi-year average or by explicitly modeling what the company earns in an average year. Then calculate the multiple using that figure, not last year's earnings or an assumed peak. This requires judgment and is why it is underused.

Q: Can multiples help me time the market?

A: Multiples are lagging indicators. By the time a multiple looks extremely cheap, the bad news is often already in the price. By the time it looks extremely expensive, the good news is already in. Multiples are better for ranking stocks than for timing markets.

Related Concepts

• Earnings Quality and One-Time Items: Understanding what earnings are sustainable versus temporary is foundational to fixing multiple traps.
• Cyclical vs. Structural Earnings: Distinguishing where a company sits in its cycle is critical to interpreting multiples correctly.
• Capital Structure and Financial Risk: A multiple should reflect the risk of the capital structure; use EV-based multiples to make this explicit.
• Mean Reversion in Earnings: Cyclical and high-growth earnings revert to long-run averages, invalidating multiples based on extreme years.

Summary

Multiples are misleading because they compress many dimensions—earnings quality, growth, risk, cycle position, and accounting choices—into a single number. The same P/E ratio can reflect a bargain or a trap depending on factors the multiple ignores. Survivorship bias distorts peer groups; cyclical peaks inflate multiples at the worst time to buy; accounting discretion makes comparisons incomparable; and growth and risk are entirely absent from the metric.

Multiples are useful as a starting point for research, not as an investment thesis. The investor who buys based solely on multiples is likely to find cheap stocks that are cheap for a reason. The investor who uses multiples to screen and then analyzes quality, durability, and value will do better.

Next

Read Mean Reversion in Valuation to understand how earnings and multiples revert to long-run averages over time, and why recent performance is often the worst guide to future returns.